GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Predictive Technology Group Inc (OTCPK:PRED) » Definitions » ROE %

Predictive Technology Group (Predictive Technology Group) ROE % : -83.65% (As of Mar. 2021)


View and export this data going back to 2007. Start your Free Trial

What is Predictive Technology Group ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Predictive Technology Group's annualized net income for the quarter that ended in Mar. 2021 was $-29.55 Mil. Predictive Technology Group's average Total Stockholders Equity over the quarter that ended in Mar. 2021 was $35.32 Mil. Therefore, Predictive Technology Group's annualized ROE % for the quarter that ended in Mar. 2021 was -83.65%.

The historical rank and industry rank for Predictive Technology Group's ROE % or its related term are showing as below:

PRED's ROE % is not ranked *
in the Biotechnology industry.
Industry Median: -43.41
* Ranked among companies with meaningful ROE % only.

Predictive Technology Group ROE % Historical Data

The historical data trend for Predictive Technology Group's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Predictive Technology Group ROE % Chart

Predictive Technology Group Annual Data
Trend Aug06 Aug07 Jun16 Jun17 Jun18 Jun19 Jun20
ROE %
Get a 7-Day Free Trial -83.31 -15.12 -9.84 -15.76 -102.07

Predictive Technology Group Quarterly Data
Nov07 Feb08 May08 Jun16 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -60.98 -208.62 -126.13 -70.10 -83.65

Competitive Comparison of Predictive Technology Group's ROE %

For the Biotechnology subindustry, Predictive Technology Group's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Predictive Technology Group's ROE % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Predictive Technology Group's ROE % distribution charts can be found below:

* The bar in red indicates where Predictive Technology Group's ROE % falls into.



Predictive Technology Group ROE % Calculation

Predictive Technology Group's annualized ROE % for the fiscal year that ended in Jun. 2020 is calculated as

ROE %=Net Income (A: Jun. 2020 )/( (Total Stockholders Equity (A: Jun. 2019 )+Total Stockholders Equity (A: Jun. 2020 ))/ count )
=-85.769/( (112.776+55.29)/ 2 )
=-85.769/84.033
=-102.07 %

Predictive Technology Group's annualized ROE % for the quarter that ended in Mar. 2021 is calculated as

ROE %=Net Income (Q: Mar. 2021 )/( (Total Stockholders Equity (Q: Dec. 2020 )+Total Stockholders Equity (Q: Mar. 2021 ))/ count )
=-29.548/( (38.312+32.332)/ 2 )
=-29.548/35.322
=-83.65 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Mar. 2021) net income data. ROE % is displayed in the 30-year financial page.


Predictive Technology Group  (OTCPK:PRED) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Mar. 2021 )
=Net Income/Total Stockholders Equity
=-29.548/35.322
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-29.548 / 27.576)*(27.576 / 68.7055)*(68.7055 / 35.322)
=Net Margin %*Asset Turnover*Equity Multiplier
=-107.15 %*0.4014*1.9451
=ROA %*Equity Multiplier
=-43.01 %*1.9451
=-83.65 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Mar. 2021 )
=Net Income/Total Stockholders Equity
=-29.548/35.322
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-29.548 / -29.592) * (-29.592 / -12.936) * (-12.936 / 27.576) * (27.576 / 68.7055) * (68.7055 / 35.322)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.9985 * 2.2876 * -46.91 % * 0.4014 * 1.9451
=-83.65 %

Note: The net income data used here is four times the quarterly (Mar. 2021) net income data. The Revenue data used here is four times the quarterly (Mar. 2021) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Predictive Technology Group ROE % Related Terms

Thank you for viewing the detailed overview of Predictive Technology Group's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Predictive Technology Group (Predictive Technology Group) Business Description

Traded in Other Exchanges
N/A
Address
2735 Parleys Way, Suite 205, Salt Lake City, UT, USA, 84109
Predictive Technology Group Inc (PRx) is a biotechnology company. It develops, commercializes, acquires and invests in technologies engaged in novel molecular diagnostic and therapeutic products in healthcare. The HCT/P segment offers minimally manipulated tissue products intended for homologous use, prepared utilizing proprietary extraction methods that reduce the loss of important scaffolding, growth factors and cytokines. The company's Diagnostics and Therapeutics segment uses data analytics for disease identification and subsequent therapeutic intervention through novel gene-based diagnostics, and companion therapeutics. It generates most of its revenues from HCT/Ps segment.

Predictive Technology Group (Predictive Technology Group) Headlines

From GuruFocus

Predictive Laboratories Launches FertilityDX™

By Marketwired Marketwired 10-14-2019